The San Carlos CLINICAL Hospital hosted a visit from the Boehringer Ingelheim pharmaceutical company a few days ago.
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need.
During the visit in Spain our clinical partner SERMAS , explained the COVID-X program and highlighted its importance as startup accelerator.
